Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Abstract 6090: Integration of innate and adaptive immune signatures for early detection of cancer

Evelyn Fitzsimons, Alexander Coulton, Hongchang Fu, Marcellus Augustine, Richard Lee, James Reading, Kevin Litchfield

Cancer Res (2024) 84 (6_Supplement): 6090.

https://doi.org/10.1158/1538-7445.AM2024-6090

Published: 22 March 2024

View article titled, Abstract 6090: Integration of innate and adaptive immune signatures for early detection of cancer

Journal Articles

E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment

Cancer Res (2021) 81 (11): 2874–2887.

https://doi.org/10.1158/0008-5472.CAN-20-2052

Published: 01 June 2021

View article titled, E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment

Includes: Supplementary data

Journal Articles

Abstract 1831: Mistletoe lectin induces apoptosis in MYC-driven cancers through post-translational downregulation of c-MYC protein

Gabrielle Kennelley, Eric Yuan, Mohammad Shatat, Betsy Gauthier, Peiying Yang, Analisa Difeo, Richard Lee

Cancer Res (2020) 80 (16_Supplement): 1831.

https://doi.org/10.1158/1538-7445.AM2020-1831

Published: 15 August 2020

View article titled, Abstract 1831: Mistletoe lectin induces apoptosis in MYC-driven cancers through post-translational downregulation of c-MYC protein

Journal Articles

Abstract 2144: Mutations in ERBB4 may account for clinical resistance of melanomas to inhibitors of the RAS/RAF/MEK/MAPK pathway

Richard Lee Cullum, Taraswi Ghosh, Lauren Lucas, Damien Waits, David Riese

Cancer Res (2019) 79 (13_Supplement): 2144.

https://doi.org/10.1158/1538-7445.AM2019-2144

Published: 01 July 2019

View article titled, Abstract 2144: Mutations in ERBB4 may account for clinical resistance of melanomas to inhibitors of the RAS/RAF/MEK/MAPK pathway

Journal Articles

Abstract 1596: Phase I trial of recombinant human Interleukin 15 (rhIL-15) administered as continuous intravenous infusion (CIV) for 10 days (240 hours) in patients with refractory metastatic cancers

Kevin C. Conlon, Sigrid Dubois, Chyi-chia Richard Lee, Thomas Fleisher, Jennifer I. Hsu, Thomas A. Waldmann

Cancer Res (2017) 77 (13_Supplement): 1596.

https://doi.org/10.1158/1538-7445.AM2017-1596

Published: 01 July 2017

View article titled, Abstract 1596: Phase I trial of recombinant human Interleukin 15 (rhIL-15) administered as continuous intravenous infusion (CIV) for 10 days (240 hours) in patients with refractory metastatic cancers

Journal Articles

Abstract 4829: Development of rapid 3-dimensional culture conditions that support the in vitro differentiation of conditionally reprogrammed primary prostate cells for the study of prostate cancer

Lucas James Tricoli, Deborah Berry, Erika Parasido, Aisha Naeem, Olga Rodriguez, Iman Abdelgawad, Richard Lee, Adam Feldman, Chris Albanese

Cancer Res (2017) 77 (13_Supplement): 4829.

https://doi.org/10.1158/1538-7445.AM2017-4829

Published: 01 July 2017

View article titled, Abstract 4829: Development of rapid 3-dimensional culture conditions that support the in vitro differentiation of conditionally reprogrammed primary prostate cells for the study of prostate cancer

Journal Articles

Abstract SY24-01: High-throughput CTC detection for noninvasive cancer monitoring

Shyamala Maheswaran, Mark Kalinich, Irun Bhan, David Miyamoto, Yu Zheng, Xin Hong, Tanya Todorova Kwan, Ravi Kapur, Lecia Sequist, Ryan Sullivan, Aditya Bardia, Richard Lee, David Ting, Mehmet Toner, Daniel A. Haber

Cancer Res (2017) 77 (13_Supplement): SY24-01.

https://doi.org/10.1158/1538-7445.AM2017-SY24-01

Published: 01 July 2017

View article titled, Abstract SY24-01: High-throughput CTC detection for noninvasive cancer monitoring

Journal Articles

Abstract 4845: Fraxini and mistletoe lectins inhibit the proliferation of hepatocellular carcinoma by promoting proteasomal degradation of c-Myc

Yan Jiang, Yong Pan, Patrea R. Rhea, Richard Lee, Zhimin Lu, Peiying Yang

Cancer Res (2016) 76 (14_Supplement): 4845.

https://doi.org/10.1158/1538-7445.AM2016-4845

Published: 15 July 2016

View article titled, Abstract 4845: Fraxini and mistletoe lectins inhibit the proliferation of hepatocellular carcinoma by promoting proteasomal degradation of c-Myc

Journal Articles

Abstract 3206: Mistletoe extract inhibits the proliferation of human hepatocellular carcinoma cells by induction of apoptosis and downregulation of c-MYC

Xiaoping Ding, Carrie Cartwright, Lin Tan, Richard Lee, Peiying Yang

Cancer Res (2014) 74 (19_Supplement): 3206.

https://doi.org/10.1158/1538-7445.AM2014-3206

Published: 01 October 2014

View article titled, Abstract 3206: Mistletoe extract inhibits the proliferation of human hepatocellular carcinoma cells by induction of apoptosis and downregulation of c-MYC

Journal Articles

Abstract SY30-01: Molecular characterization of single circulating tumor cells.

Daniel A. Haber, Min Yu, Emre Ozkumar, David Ting, David Miyamoto, Richard Lee, Ajay Shah, Aditya Bardia, Shannon Stott, Mehmet Toner, Shyamala Maheswaran

Cancer Res (2013) 73 (8_Supplement): SY30-01.

https://doi.org/10.1158/1538-7445.AM2013-SY30-01

Published: 15 April 2013

View article titled, Abstract SY30-01: Molecular characterization of single circulating tumor cells.

Journal Articles

Abstract 156: Prognostic significance of distance travelled to the cancer center in women treated with adjuvant trastuzumab.

Sarah Roberts, Sabuj Sarker, Richard Lee-Ying, Charanpreeti Ubhi, Shahid Ahmed

Cancer Res (2013) 73 (8_Supplement): 156.

https://doi.org/10.1158/1538-7445.AM2013-156

Published: 15 April 2013

View article titled, Abstract 156: Prognostic significance of distance travelled to the cancer center in women treated with adjuvant trastuzumab.

Journal Articles

Abstract 2562: Efficacy of RG7204 (PLX4032), a selective BRAF^V600E inhibitor, in combination with pegylated interferon alpha-2a (Pegasys), paclitaxel, carboplatin, and anti-VEGF MAb B20-4.1 in the LOX-IMVI human melanoma xenograft model

Brian Higgins, Kenneth Kolinksy, Zenaida Go, Hing Char, Richard Lee, Kathleen Schostack, Gideon Bollag, David Heimbrook, Fei Su, Kathryn E. Packman

Cancer Res (2011) 71 (8_Supplement): 2562.

https://doi.org/10.1158/1538-7445.AM2011-2562

Published: 15 April 2011

View article titled, Abstract 2562: Efficacy of RG7204 (PLX4032), a selective BRAFV600E inhibitor, in combination with pegylated interferon alpha-2a (Pegasys), paclitaxel, carboplatin, and anti-VEGF MAb B20-4.1 in the LOX-IMVI human melanoma xenograft model

Journal Articles

RG7204 (PLX4032), a Selective BRAF^V600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models

Hong Yang, Brian Higgins, Kenneth Kolinsky, Kathryn Packman, Zenaida Go, Raman Iyer, Stanley Kolis, Sylvia Zhao, Richard Lee, Joseph F. Grippo, Kathleen Schostack, Mary Ellen Simcox, David Heimbrook, Gideon Bollag, Fei Su

Cancer Res (2010) 70 (13): 5518–5527.

https://doi.org/10.1158/0008-5472.CAN-10-0646

Published: 30 June 2010

View article titled, RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models

Includes: Supplementary data

Journal Articles

Glomus Tumors in Neurofibromatosis Type 1: Genetic, Functional, and Clinical Evidence of a Novel Association

Hilde Brems, Caroline Park, Ophélia Maertens, Alexander Pemov, Ludwine Messiaen, Meena Upadhyaya, Kathleen Claes, Eline Beert, Kristel Peeters, Victor Mautner, Jennifer L. Sloan, Lawrence Yao, Chyi-Chia Richard Lee, Raf Sciot, Luc De Smet, Eric Legius, Douglas R. Stewart

Cancer Res (2009) 69 (18): 7393–7401.

https://doi.org/10.1158/0008-5472.CAN-09-1752

Published: 14 September 2009

View article titled, Glomus Tumors in Neurofibromatosis Type 1: Genetic, Functional, and Clinical Evidence of a Novel Association

Includes: Supplementary data

Journal Articles

Abstract #4420: PLX4032, a selective B-Raf^V600E inhibitor demonstrates potent antitumor activity in preclinical melanoma models

Fei Su, Hong Yang, Brian Higgins, Kenneth Kolinsky, Richard Lee, Kathryn Packman, Kathleen Schostack, David Heimbrook, Gideon Bollag

Cancer Res (2009) 69 (9_Supplement): 4420.

Published: 01 May 2009

View article titled, Abstract #4420: PLX4032, a selective B-RafV600E inhibitor demonstrates potent antitumor activity in preclinical melanoma models

Journal Articles

Tissue heterogeneity correction in gene expression mapping

Jianhua Xuan, Richard Lee, Yuelin Zhu, Alan L. Zwart, Robert Clarke, Yue Wang

Cancer Res (2004) 64 (7_Supplement): 378–379.

Published: 01 April 2004

View article titled, Tissue heterogeneity correction in gene expression mapping

Journal Articles

Mammary gland gene expression patterns in rats at elevated breast cancer risk due to being exposed to estradiol or leptin during pregnancy

Mingyue Wang, Richard Lee, Yuelin Zhu, Sonia Deassis, Joseph Wang, Robert Clarke, Leena H. Clarke

Cancer Res (2004) 64 (7_Supplement): 320–321.

Published: 01 April 2004

View article titled, Mammary gland gene expression patterns in rats at elevated breast cancer risk due to being exposed to estradiol or leptin during pregnancy

Journal Articles

ΔNp63α and TAp63α Regulate Transcription of Genes with Distinct Biological Functions in Cancer and Development

Guojun Wu, Shuji Nomoto, Mohammad Obaidul Hoque, Tatiana Dracheva, Motonabu Osada, Chyi-Chia Richard Lee, Seung Myung Dong, Zhongmin Guo, Nicole Benoit, Yoram Cohen, Peggy Rechthand, Joseph Califano, Chul-so Moon, Edward Ratovitski, Jin Jen, David Sidransky, Barry Trink

Cancer Res (2003) 63 (10): 2351–2357.

Published: 15 May 2003

View article titled, ΔNp63α and TAp63α Regulate Transcription of Genes with Distinct Biological Functions in Cancer and Development

NARROW

Abstract 6090: Integration of innate and adaptive immune signatures for early detection of cancer

E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment

Abstract 1831: Mistletoe lectin induces apoptosis in MYC-driven cancers through post-translational downregulation of c-MYC protein

Abstract 2144: Mutations in ERBB4 may account for clinical resistance of melanomas to inhibitors of the RAS/RAF/MEK/MAPK pathway

Abstract 1596: Phase I trial of recombinant human Interleukin 15 (rhIL-15) administered as continuous intravenous infusion (CIV) for 10 days (240 hours) in patients with refractory metastatic cancers

Abstract 4829: Development of rapid 3-dimensional culture conditions that support the in vitro differentiation of conditionally reprogrammed primary prostate cells for the study of prostate cancer

Abstract SY24-01: High-throughput CTC detection for noninvasive cancer monitoring

Abstract 4845: Fraxini and mistletoe lectins inhibit the proliferation of hepatocellular carcinoma by promoting proteasomal degradation of c-Myc

Abstract 3206: Mistletoe extract inhibits the proliferation of human hepatocellular carcinoma cells by induction of apoptosis and downregulation of c-MYC

Abstract SY30-01: Molecular characterization of single circulating tumor cells.

Abstract 156: Prognostic significance of distance travelled to the cancer center in women treated with adjuvant trastuzumab.

Abstract 2562: Efficacy of RG7204 (PLX4032), a selective BRAF^V600E inhibitor, in combination with pegylated interferon alpha-2a (Pegasys), paclitaxel, carboplatin, and anti-VEGF MAb B20-4.1 in the LOX-IMVI human melanoma xenograft model

RG7204 (PLX4032), a Selective BRAF^V600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models

Glomus Tumors in Neurofibromatosis Type 1: Genetic, Functional, and Clinical Evidence of a Novel Association

Abstract #4420: PLX4032, a selective B-Raf^V600E inhibitor demonstrates potent antitumor activity in preclinical melanoma models

Tissue heterogeneity correction in gene expression mapping

Mammary gland gene expression patterns in rats at elevated breast cancer risk due to being exposed to estradiol or leptin during pregnancy

ΔNp63α and TAp63α Regulate Transcription of Genes with Distinct Biological Functions in Cancer and Development

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only